Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults

The multicomponent meningococcal serogroup B vaccine, 4CMenB, has demonstrated effectiveness in preventing invasive MenB disease in infants and in controlling MenB outbreaks. The need for/timing of additional booster doses is not yet established. We reviewed eight studies that evaluated antibody per...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinón-Torres, Federico, Nolan, Terry, Toneatto, Daniela, Banzhoff, Angelika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930112/
https://www.ncbi.nlm.nih.gov/pubmed/31246520
http://dx.doi.org/10.1080/21645515.2019.1627159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930112/
https://www.ncbi.nlm.nih.gov/pubmed/31246520
http://dx.doi.org/10.1080/21645515.2019.1627159

Ejemplares similares